Top 10 Pharma Companies in India 2022

Are you looking for the List Top 10 Pharma Companies in India in 2022? if yes, you are in the right place. India is among the leading global producer of cost-effective medicines and vaccines, supplying a total of 20% of the total global demand by volume.

Today, India is among the countries with an established domestic pharmaceutical industry, with a strong network of 3000 national and multinational drug companies and more than 10,500 manufacturing units.

10. Mankind Pharma Limited


Mankind Pharma Limited was founded in 1995 by R.C. Juneja and Rajeev Juneja based at New Delhi. and this is the best among all pharma companies in India.

The company has products in therapeutic areas ranging from antibiotics to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.

The company has a revenue of more than INR 52 billion with over 14000 employees working together for the company’s growth and development.

The company focuses mainly on chronic segments/lifestyle diseases and that generates long-term prescriptions. It also focuses on the OTC division where it has leading brands like Manforce, Preganews, Acnestar, Gasofast, Unwanted 72.

FOUNDERR_C_Juneja, Rajeev Juneja
HEADQUARTERSOkhla Phase III, Delhi , India
KEY PEOPLEPriyanshu Mohan, Arjun Juneja, Sheetal Arora, P.K. Arora, Ajay Bansal, Sanjay Koul
PRODUCTSPharmaceuticals, Generic drugs, OTC, FMCG, Diagnostics
REVENUEINR 5000 Crores (2017-18)
SUBSIDIARIESDiscovery, Lifestar, Lifestar 2, Special, Vet, Future, Magnet  

9. Intas Pharmaceuticals Limited

image 1

Intas Pharmaceutical Limited set up in 1984 by Binnish Chudgar was formerly an independent biotechnology company and was known as Intas biopharmaceuticals ltd. Headquartered in Ahmedabad, the company is the leading biosimilar product manufacturers in Asia. intas pharma is also one of the top pharma companies in India.

Intas has 13 commercialized biosimilars including Docetaxel and Paclitaxel. As on date, Intas continues its R&D efforts in chronic disease areas such as oncology, rheumatology, auto-immune, nephrology, ophthalmology, and plasma-derived product based therapies. Intas has 14 formulation manufacturing facilities of which seven are located in India, and the rest in the U.K. and Mexico.

In FY 2018, the company’s revenue was INR 108 billion with an overall growth of 29.84% over last year’s revenue.

Intas is currently investing in a higher barrier to entry developments such as biosimilar and new chemical entities and is set to continue raising the bar of healthcare excellence globally in the near future.

HEADQUARTERSAhmedabad, India
PRODUCTSNeukine (GCSF), Erykine (EPO), Intalfa (IFN), Pegasta (Peg GCSF), Terifrac (Teriparatide), Mabtas (Rituximab), Folisurge (FSH)

8. Torrent Pharmaceuticals Limited

image 2

Headquartered in Ahmedabad, Torrent Pharmaceuticals Ltd. It is the flagship company of the Torrent Group. Promoted by U.N. Mehta.

The company operates in more than 40 countries having a number of employees of around 14000 with total revenue of INR 7673 Cr in 2019. Torrent Pharma is active in the therapeutic areas of Cardiovascular, CNS, Gastro-intestinal, diabetology, anti-infective, and pain management segments. The key products include calcium Carbonate along with Vitamin D3, Losartan, Rosuvastatin.

The company in 2017 has completed the acquisition of the branded business of Unichem Laboratories Limited. Brand building is its key priority and currently, 19 brands (Shelcal is among the top one) features amongst the top 500 brands. torrent is also known as best company among all top pharma companies in India.

The company is developing several in-house new chemical entities in the areas of metabolic, cardiovascular, gastrointestinal, dermatological and respiratory disorders. The most advanced discovery program of the company is the NCE for the reduction of cardiovascular risk. The next advanced discovery program is for the management of heart failure in diabetic patients.

Given the future market moving towards complex products, Torrent is ramping up is a pipeline with products like oral liquids, ophthalmic, ointments & creams, and oncology.

HEADQUARTERSAhmedabad, India
KEY PEOPLESudhir Mehta, Samir Mehta
REVENUEINR 7673 Cr (March 2019)
NET INCOMEINR 436 Cr (March 2019)

7. Cadila Healthcare Limited

image 3

Cadila Healthcare Limited is a well-known research-oriented, a technology-driven pharmaceutical company headquartered at Ahmedabad, Gujarat which focuses on research areas of biotechnology, formulations, and Active Pharmaceutical Ingredients (API). Cadila is also one of the top pharma companies in india.

The company was founded in 1952 by Ramanbhai Patel, formerly a lecturer in the L.M. College of Pharmacy. It evolved over the next four decades into an established pharmaceutical company. In June 2007, the company acquired Nikkho as part of Zydus Healthcare Brasil Ltd. In 2015, the company acquired another Indian pharmaceutical company called German Remedies.

Cadila Healthcare Limited provides total healthcare solutions ranging from formulations, active pharmaceutical ingredients (APIs), and animal healthcare products to wellness products.

Cadila Healthcare Limited is India’s sixth-largest pharmaceutical company based on overall revenue. In FY 2019, the company’s revenue was INR 131 billion which saw an increase of 10% y-o-y revenue in FY 2018.

The company has 9 production operations in India that develop and manufactures a large range of pharmaceutical as well as diagnostics, herbal products, skin care products, and other OTC products. The company also produces the generics for hepatitis C treatment i.e. sofosbuvir as SoviHep. Injectable ketorolac tromethamine is manufactured by Zydus Cadila for the microbial growth. The company is ranked among the top three players in the promoted covered market of gynecology, dermatology, respiratory, pain management, cardiovascular and gastrointestinal therapeutic areas.

FOUNDERRamanbhai Patel
HEADQUARTERSAhmedabad, Gujarat, India
KEY PEOPLEPankaj R. Patel, Chairman, Sharvil P. Patel, Managing Director
REVENUEINR 119.05 Billion (2018)
NET INCOMEINR 17.76 Billion (2018)

6. Glenmark Pharmaceuticals

image 4

Glenmark is a pharmaceutical company headquartered in Mumbai, India that was founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer. Glenmark is also the best company among all Pharma Companies in India.

The company primarily focused on new drugs and biosimilars in the fields of cancer dermatology and respiratory diseases. Glenmark is a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity).

Glenmark also entered the exclusive licensing agreement with Australia’s Sequirus to commercialize its nasal spray Ryaltris (a fixed those combinations of antihistamine and a steroid) for the treatment of seasonal allergic rhinitis (SAR).

The company has 17 manufacturing facilities globally and 5 R&D centers in India and Switzerland with gross revenue of INR 91 billion. The company has over 12,000 dedicated employees worldwide.

FOUNDERSGracias Saldanha
KEY PEOPLEGlenn Saldanha, MD & Chairman
PRODUCTSMedicines and vaccines

5. Lupin Limited

image 5

Headquartered in Mumbai, Maharashtra, India, Lupin Limited is a multinational pharmaceutical company founded by Desh Bandhu Gupta in the year 1968. Lupin is also one of the best Pharma Companies in India.

The company is a significant player in key therapy areas such as pediatrics, cardiovascular, anti-infectives, diabetology, asthma, and anti-tuberculosis from which collected total revenue of INR 155.77 billion in 2018-19. Lupin stands 1st in the anti-TB segment globally. Around 50000 employees work globally for the company’s progress and development.

The company’s research program covers the entire pharma product chain. Lupin’s R&D covers generics research, process research, pharmaceutical research, ADDS research, intellectual property management, Novel Drug Discovery and Development, and biotechnology research.

In FY 2019, the company launched 22 new products in the US market. The company launched Solosec® successfully in the US and started women’s health specialty business in full intensity. The company also launched the first orphan drug – NaMuscla® in the UK, Germany, and France.

The company also focuses on social responsibility and thus, has a foundation under the name The Lupin Human Welfare and Research Foundation (LHWRF).

In FY 2020, Lupin is planning to bring its first biosimilar to market, commercialize its first inhalation product in the US and launch an injectables portfolio.

FOUNDERDesh Bandhu Gupta
HEADQUARTERSMumbai, Maharashtra , India
KEY PEOPLEVinita D. Gupta, Chief Executive Officer; Nilesh Gupta, Managing director Dr Kamal Sharma, Vice Chairman
PRODUCTSPharmaceuticals, branded and generic drugs,
REVENUE$2.55 billion USD (2016-2017)
NET INCOME$721 million USD (2016-2017)
SUBSIDIARIESLupin Pharmaceuticals, Inc. , Kyowa Pharmaceutical Industry Co. Ltd, I’rom Pharmaceutical Co. Ltd., Pharma Dynamics, Multicare Pharmaceuticals, Generic Health Pte. Ltd. Hormosan Pharma GmbH Nanomi B.V., Laboratorios Grin, Medquimica, Biocom Russia, Temmer Germany  

4. Dr. Reddy’s Laboratories Limited

image 6

Dr. Reddy’s was founded in 1984 by Anji Reddy in Hyderabad, Telangana, India. The company began as a supplier to Indian Drug manufacturers. it is also the best company among all Pharma Companies in India.

In 1987, Reddy’s launched Norilet, the company’s first recognized brand in India. Reddy’s also became the first Indian company to export the active ingredients for pharmaceuticals to Europe.

The company had a total revenue of US$2.1 billion in 2017-18. Around 22000 employees work worldwide for Dr.Reddy’s Pharma.

The atop active pharmaceutical ingredients from Dr.Reddy’s Pharma include ranitidine, losartan, clopidogrel, Ramipril, atorvastatin, and many others.

In 1992, Reddy’s formed a joint venture with Biomed, the biggest pharmaceutical producer in Russia.

Reddy’s also involved in targeting specialty generics products in western markets to create a foundation for drug discovery. In 1992, Dr.Reddy’s research foundation was established in order to do research in the area of new drug discovery.

Reddy’s research thrust focuses on large niche areas in western markets – anti-cancer, anti-diabetics, cardiovascular and anti-infection drugs.

HEADQUARTERSHyderabad, Telangana, India
KEY PEOPLEG. V. Prasad (Co-Chairman & CEO)
Satish Reddy (Chairman)
Erez Israeli (Chief Operating Officer)
Saumen Chakraborty (Chief Financial Officer)
REVENUE ₹14,203 crore (US$2.0 billion) (FY 2017-2018)
NET INCOME ₹981 crore (US$140 million) (FY 2017-2018)
TOTAL ASSETS ₹22,560.4 crore (US$3.2 billion) (March 2018)
TOTAL EQUITY ₹12,646.0 crore (US$1.8 billion) (March 2018)
NUMBER OF EMPLOYEES21,966 (March 2019)  

3. Aurobindo Pharma

image 7

Aurobindo Pharma Limited is a pharmaceutical manufacturing company headquartered in HITEC CITY, Hyderabad, India. The company was founded by P.V. Ramprasad Reddy and K. Nityanand Reddy in 1986 but commenced operations in 1988-89 with a single unit manufacturing semi-synthetic penicillin (SSP) in Puducherry. it is also the best company among all Pharma Companies in India

Aurobindo Pharma has a key presence in therapeutic segments such as neurosciences, cardiovascular, anti-retroviral, anti-diabetics, gastroenterology, and cephalosporins.

The company has 2 manufacturing facilities worldwide with 22000+ employees globally. The company manufactured more than around 33 billion diverse dosage forms in 2018-19 making revenue of US$ 2.8 billion in 2018-19. this is one of the best Pharma Companies in India.

The company has launched 50 new products, including 12 injectables in the market in 2018-19.

Aurobindo Pharma plans to expand its product portfolio with high-value products in oncology, hormones biosimilars and novel drug delivery solutions like depot injections, inhalers, patches, and films.

The company focuses on scaling up to LEAP ahead where LEAP stands for Lead with a range of products; Expand into new areas; Attaining capabilities and strengthening compliance; Promote an execution-oriented growth mindset.

HEADQUARTERSHyderabad, Telangana, India
Organic Intermediates
REVENUE ₹136.50 billion (US$1.9 billion) (2017)
NET INCOME ₹19.780 billion (US$280 million) (2017)
NUMBER OF EMPLOYEES19000 (March 2017)  

2. Cipla Limited

image 8

Cipla was founded by Khwaja Abdul Hamied as ‘The Chemical, Industrial and Pharmaceutical Laboratories’ in 1935 in Mumbai. Cipla has a major sale of Active Pharmaceutical ingredients to other manufacturers for marketing. It also has a sale of pharmaceutical and personal care products, including Escitalopram (anti-depressant), Lamivudine, and Fluticasone propionate.

The company is the world’s largest manufacturer of antiretroviral drugs and a therapy leader in India for anti-malarial with a market share of over 34%. The company manufactured the world’s first oral iron chelator with the name, Deferiprone in 1995. Cipla is the top company among all top Pharma Companies in India

Cipla has 34 manufacturing units in 8 locations across India and a presence in over 80 countries with around 26000 employees working in making Cipla one of the top pharmaceutical companies in India as well as in the world.

Cipla has a total net worth of US$4 billion with an increase of 4.83 % over the revenue. The company spends over 7.4% of its revenue on R&D activities.

The primary focus areas for R&D is the development of new formulations, drug-delivery systems, and APIs. The company also focuses on closely monitoring the repurposing and repositioning of existing drugs. The interesting area of research includes prodrugs, metabolites, liposomal drugs, Nano-particles, and many more. The ultimate objective is to develop products for faster regulatory approvals in the niche market.

FOUNDERKhwaja Abdul Hamied
HEADQUARTERSMumbai, Maharashtra, India
KEY PEOPLEY. K. Hamied, Chairman
Umang Vohra (CEO)
PRODUCTSPharmaceuticals and diagnostics
REVENUEUS$3.5 billion (2017-18)
OPERATING INCOMEUS$1.5 billion (2017-18)
NET INCOMEUS$4 billion (2017-18)
TOTAL ASSETSUS$5 billion (2017-18)
TOTAL EQUITYUS$2 billion (2017-18)
SUBSIDIARIESInvagen Pharmaceuticals
Source : Wikipedia

1. Sun Pharmaceuticals Industries Limited

image 9

SUN PHARMA is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra known for the manufacturing and selling of pharmaceutical formulations and active pharmaceutical ingredients (APIs).

The company was founded in the year 1983 by Dilip Sanghvi (now the Managing Director of Sun Pharma) in Vapi, Gujarat with five products to treat psychiatry ailments. sun pharma is no. 1 company among all top Pharma Companies in India.

Today, the company’s major therapeutic areas including cardiology, psychiatry, neurology, gastroenterology, and diabetology. The company also provides Active Pharmaceutical Ingredients (APIs) such as warfarin as blood diluters, carbamazepine as anti-convulsant, etodolac as NSAID, and clorazepate as well as anti-cancers, steroids, peptides, sex hormones, and controlled substances.

After Acquiring RANBAXY in the year 2014, Sun Pharma became India’s top pharma company with a net worth of US$390 million (2019) and around 32, 000 employees (2019).

Sun Pharma has many other acquisitions and joint ventures with many foreign companies that proved to be the major milestones for the company’s development and success. This year company commercialized ILUMYA TM, YONSATM, and XELPROSTM in the US. CEQUATM is expected to be launched in the US in FY20.

The company is expecting to continue to build a global specialty pipeline with focused research and development (R&D) investments with its demerged arm SPARC. The principal focus areas for specialty portfolio include segments like dermatology, ophthalmology, and oncology.

FOUNDERDilip Shanghvi
HEADQUARTERSMumbai, Maharashtra , India
KEY PEOPLEDilip Shanghvi
(managing director)
PRODUCTSPharmaceuticals, generic drugs
REVENUE ₹300,914 million (US$4.2 billion) (2019)
OPERATING INCOME ₹38,102 million (US$530 million) (2019)
NET INCOME ₹26,654 million (US$370 million) (2019)
TOTAL ASSETS ₹646,938 million (US$9.1 billion) (2019)
TOTAL EQUITY ₹447,226 million (US$6.3 billion) (2019)

Conclusion :

This was the list of India based Top 10 pharma companies in India based on the y-o-y revenue. We have Provided the Complete Profile of the Companies .Also There are many more other top companies like Biocon Limited, Piramal Enterprises Limited, Wockhardt Limited, Divis Laboratories Limited, Abbott India Limited, etc.